Company news

NextCure, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NextCure Provides Business Update and Reports First Quarter 2022 Financial Results

May 4, 2022

NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

March 2, 2022

NextCure Reports Third Quarter 2021 Financial Results and Provides Business Update

November 3, 2021

NextCure Announces Three New Members of its Scientific Advisory Board

October 18, 2021

NextCure Announces Publication of Preclinical Data for NC410

October 6, 2021

NextCure Announces New Appointments to its Board of Directors

October 3, 2021

NextCure Reports Second Quarter 2021 Financial Results

August 4, 2021

NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors

July 5, 2021

NextCure Reports First Quarter 2021 Financial Results

May 5, 2021

NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

March 3, 2021

Dr. Han Myint Appointed as NextCure’s Chief Medical Officer

January 13, 2021

NextCure Provides Updates on NC318 Clinical Program

December 16, 2020

NextCure Reports Third Quarter 2020 Financial Results

November 4, 2020

NextCure Announces Appointment of John G. Houston, Ph.D., to its Board of Directors

September 13, 2020

NextCure Reports Second Quarter 2020 Financial Results

August 5, 2020

NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical Officer

July 12, 2020

NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors

July 6, 2020

NextCure Reports First Quarter 2020 Financial Results

May 6, 2020

NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic

April 12, 2020

NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors

March 29, 2020

NextCure Reports Fourth Quarter and Full Year 2019 Financial Results

March 11, 2020

NextCure Announces Closing of Public Offering

November 18, 2019

NextCure Announces Pricing of Public Offering of Common Stock

November 13, 2019

NextCure Reports Third Quarter 2019 Financial Results

November 11, 2019

NextCure Announces Proposed Public Offering of Common Stock

November 11, 2019

NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial

November 8, 2019

NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer

October 1, 2019

NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC

September 30, 2019

← Newer news releases

Decks

The 5 newest of 15 decks. Every deck is listed under its year.